Your browser doesn't support javascript.
loading
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer.
Rami-Porta, Ramón; Nishimura, Katherine K; Giroux, Dorothy J; Detterbeck, Frank; Cardillo, Giuseppe; Edwards, John G; Fong, Kwun M; Giuliani, Meredith; Huang, James; Kernstine, Kemp H; Marom, Edith M; Nicholson, Andrew G; Van Schil, Paul E; Travis, William D; Tsao, Ming S; Watanabe, Shun-Ichi; Rusch, Valerie W; Asamura, Hisao.
Afiliación
  • Rami-Porta R; Department of Thoracic Surgery, Hospital Universitari Mutua Terrassa, University of Barcelona, Terrassa, Barcelona, Spain; Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Barcelona, Spain. Electronic address: rramip@yahoo.es.
  • Nishimura KK; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
  • Giroux DJ; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
  • Detterbeck F; Department of Surgery, Yale University, New Haven, Connecticut.
  • Cardillo G; Department of Thoracic Surgery, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy; UniCamillus-Saint Camillus International University of Health Science, Rome, Italy.
  • Edwards JG; Department of Cardiothoracic Surgery, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, United Kingdom.
  • Fong KM; Department of Thoracic Medicine, University of Queensland Thoracic Research Centre, The Prince Charles Hospital, Chermside, Brisbane, Queensland, Australia.
  • Giuliani M; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Huang J; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kernstine KH; Cardiovascular and Thoracic Surgery, University of Texas Southwestern, Dallas, Texas.
  • Marom EM; The Chaim Sheba Medical Center, University of Tel Aviv, Tel Aviv, Israel.
  • Nicholson AG; Department of Histopathology, Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Van Schil PE; Department of Thoracic and Vascular Surgery, Antwerp University Hospital and Antwerp University, Edegem (Antwerp), Belgium.
  • Travis WD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tsao MS; Department of Pathology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Watanabe SI; Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Rusch VW; Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Asamura H; Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan.
J Thorac Oncol ; 2024 Mar 04.
Article en En | MEDLINE | ID: mdl-38447919
ABSTRACT

INTRODUCTION:

The TNM classification of lung cancer is periodically revised. The International Association for the Study of Lung Cancer collected and analyzed a new database to inform the forthcoming ninth edition of the TNM classification. The results are herewith presented.

METHODS:

After exclusions, 76,518 patients from a total of 124,581 registered patients were available for analyses 58,193 with clinical stage, 39,192 with pathologic stage, and 62,611 with best stage NSCLC. The proposed new N2 subcategories (N2a, involvement of single ipsilateral mediastinal or subcarinal nodal station, and N2b, involvement of multiple ipsilateral mediastinal nodal stations with or without involvement of the subcarinal nodal station) and the new M1c subcategories (M1c1, multiple extrathoracic metastases in one organ system, and M1c2, multiple extrathoracic metastases in multiple organ systems) were considered in the survival analyses. Several potential stage groupings were evaluated, using multiple analyses, including recursive partitioning, assessment of homogeneity within and discrimination between potential groups, clinical and statistical significance of survival differences, multivariable regression, and broad assessment of generalizability.

RESULTS:

T1N1, T1N2a, and T3N2a subgroups are assigned to IIA, IIB, and IIIA stage groups, respectively. T2aN2b and T2bN2b subgroups are assigned to IIIB. M1c1 and M1c2 remain in stage group IVB. Analyses reveal consistent ordering, discrimination of prognosis, and broad generalizability of the proposed ninth edition stage classification of lung cancer.

CONCLUSIONS:

The proposed stages for the ninth edition TNM improve the granularity of nomenclature about anatomic extent that has benefits as treatment approaches become increasingly differentiated and complex.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Thorac Oncol Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Thorac Oncol Año: 2024 Tipo del documento: Article
...